Harte-Hanks (HHS) Misses Q3 EPS by 72c
Tweet
Share
E-mailGet Alerts HHS Hot Sheet
Price: $3.68 +1.94%
Financial Fact:
Total operating expenses: 102M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Total operating expenses: 102M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Harte-Hanks (NASDAQ: HHS) reported Q3 EPS of ($0.31), $0.72 worse than the analyst estimate of $0.41. Revenue for the quarter came in at $39.5 million versus the consensus estimate of $51.7 million.
For earnings history and earnings-related data on Harte-Hanks (HHS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA maintains underperform ratings on six BDC stocks
- Myriad Uranium completes acquisition of Rush Rare Metals
- Kimbell Royalty closes $221.2M mineral rights acquisition
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
